This book examines the role of patents and intellectual property (IP) in the pharmaceutical industry. It covers patent strategies, IP protection mechanisms, and legal considerations in drug development and commercialization. The book emphasizes the importance of safeguarding innovations to foster research and development in pharma. Suitable for pharmaceutical executives and legal professionals, it promotes effective IP management in the industry.
Evelyn Dunn is a Pharmaceutical Lawyer and Professor specializing in intellectual property law. She has published over 60 articles and edited 3 books on pharmaceutical patents. Evelyn’s expertise lies in patent strategy, regulatory frameworks, and intellectual property protection in the drug development process. Her work supports innovators in safeguarding their pharmaceutical advancements globally.